Mounjaro® (Tirzepatide)


Mounjaro® (Tirzepatide) – Medical Information & Guidance

Mounjaro® (tirzepatide) is a once-weekly injectable prescription medication used in the management of type 2 diabetes and, in some cases, weight management under medical supervision.

This page provides general medical information about Mounjaro and its use in Thailand. Fulfil Pharma Pattaya can provide professional guidance and help direct patients appropriately.


What is Mounjaro (Tirzepatide)?

    • Mounjaro® contains tirzepatide, a medication that works on two hormone systems involved in blood sugar control and appetite regulation:

      • GLP-1 (glucagon-like peptide-1)
      • GIP (glucose-dependent insulinotropic polypeptide)

      This dual mechanism makes it different from traditional GLP-1 medications such as Ozempic and similar treatments available in Thailand.


How It Works

    • GLP-1 receptor action in Mounjaro (Tirzepatide): boosts insulin, lowers glucagon, slows stomach emptying.

    • GIP receptor action in Mounjaro  (Tirzepatide): improves insulin response and supports weight management.

    • Combined, this dual action makes Mounjaro (Tirzepatide) more effective than traditional single-incretin drugs.


Dosage & Administration

Keep it practical:

    • Starting dose: 2.5 mg once weekly (subcutaneous injection).

    • Titration: can increase every 4 weeks up to 15 mg weekly based on tolerance.

    • Injection sites: abdomen, thigh, or upper arm.


Benefits

    • Significant blood sugar control: Mounjaro (Tirzepatide) reduces HbA1c around 2% or more.

    • Weight loss potential: Many patients lose a noticeable amount of weight after using Mounjaro (Tirzepatide).

    • Once-weekly injection: Convenient for busy lifestyles.


Side Effects & Precautions

    • Common side effects: nausea, diarrhea, vomiting, constipation, decreased appetite.

    • Serious risks (rare): pancreatitis, gallbladder problems, thyroid C-cell tumors (in rodents).

    • Who should avoid: people with history of medullary thyroid carcinoma or MEN2 syndrome.


Conclusion

Mounjaro (Tirzepatide) represents a new era in diabetes care, offering powerful blood sugar control along with weight loss benefits. While it’s not for everyone, it provides hope for patients looking for more effective and convenient options.